Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Lu

Showing results (771-780 of 932) with videos related to

Pageof 94
Sort By:
Cancer Chemotherapy and Pharmacology|May 19, 2019
Pharmacokinetics of trastuzumab emtansine (T-DM1) as a single agent or in combination with pertuzumab in HER2-positive breast cancer patients with recurrent or locally advanced metastatic breast cancerDan Lu, Chunze Li, Matthew Riggs, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 15, 2024
[Intervention effect of Erchen Decoction on methionine and choline deficient diet-induced non-alcoholic steatohepatitis in mice]Mei-Ting Tai, Chen-Fang Zhang, Chao-Wen Fan, et al.
Acta Pharmacologica Sinica|December 1, 2021
Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart diseaseYang-Yang He, Yi Yan, Ji-Wang Chen, et al.
Current Drug Metabolism|April 6, 2012
Drug interaction potential of trastuzumab emtansine (T-DM1) combined with pertuzumab in patients with HER2-positive metastatic breast cancerDan Lu, Howard A Burris, Bei Wang, et al.
Frontiers in Immunology|August 10, 2019
Divergent Peptide Presentations of HLA-A<sup>*</sup>30 Alleles Revealed by Structures With Pathogen PeptidesShiyan Zhu, Kefang Liu, Yan Chai, et al.
Toxicology and Applied Pharmacology|December 27, 2015
Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expressionZhong-Ze Fang, Dunfang Zhang, Yun-Feng Cao, et al.
Oncotarget|September 30, 2015
A strategy to combine pathway-targeted low toxicity drugs in ovarian cancerJoe R Delaney, Chandni Patel, Katelyn E McCabe, et al.
Respiratory Research|September 10, 2020
Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosisYu-Bao Qiu, Bin-Bin Wan, Gang Liu, et al.
Optics Express|May 5, 2019
Joint clock recovery and feed-forward equalization for PAM4 transmissionHonghang Zhou, Yan Li, Dan Lu, et al.
Nature Communications|March 20, 2026
Low-intensity focused ultrasound-activated piezoelectric gel bandage for diabetic wound repair and neuropathic pain reliefXiao Li, Lizhou Lin, Mingrui Zhu, et al.
Pageof 94

Showing results (771-780 of 932) with videos related to

Sort By:
Pageof 94
Cancer Chemotherapy and Pharmacology|May 19, 2019
Pharmacokinetics of trastuzumab emtansine (T-DM1) as a single agent or in combination with pertuzumab in HER2-positive breast cancer patients with recurrent or locally advanced metastatic breast cancerDan Lu, Chunze Li, Matthew Riggs, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 15, 2024
[Intervention effect of Erchen Decoction on methionine and choline deficient diet-induced non-alcoholic steatohepatitis in mice]Mei-Ting Tai, Chen-Fang Zhang, Chao-Wen Fan, et al.
Acta Pharmacologica Sinica|December 1, 2021
Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart diseaseYang-Yang He, Yi Yan, Ji-Wang Chen, et al.
Current Drug Metabolism|April 6, 2012
Drug interaction potential of trastuzumab emtansine (T-DM1) combined with pertuzumab in patients with HER2-positive metastatic breast cancerDan Lu, Howard A Burris, Bei Wang, et al.
Frontiers in Immunology|August 10, 2019
Divergent Peptide Presentations of HLA-A<sup>*</sup>30 Alleles Revealed by Structures With Pathogen PeptidesShiyan Zhu, Kefang Liu, Yan Chai, et al.
Toxicology and Applied Pharmacology|December 27, 2015
Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expressionZhong-Ze Fang, Dunfang Zhang, Yun-Feng Cao, et al.
Oncotarget|September 30, 2015
A strategy to combine pathway-targeted low toxicity drugs in ovarian cancerJoe R Delaney, Chandni Patel, Katelyn E McCabe, et al.
Respiratory Research|September 10, 2020
Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosisYu-Bao Qiu, Bin-Bin Wan, Gang Liu, et al.
Optics Express|May 5, 2019
Joint clock recovery and feed-forward equalization for PAM4 transmissionHonghang Zhou, Yan Li, Dan Lu, et al.
Nature Communications|March 20, 2026
Low-intensity focused ultrasound-activated piezoelectric gel bandage for diabetic wound repair and neuropathic pain reliefXiao Li, Lizhou Lin, Mingrui Zhu, et al.
Pageof 94